S4DX in a €5M in a Series A round backed by SARSTEDT AG & Co. KG and the EIC Fund.

S4DX (Smart4Diagnostics), a Muncih, Germany-based manufacturer of a device for blood sample measurement, announced completing a €5M ($6M) series A capital funding round.

The money was raised from investors led by SARSTEDT AG & Co. KG and joined by the European Union's equity fund the EIC Fund.

S4DX, founded as DX Labtrack in 2018 by CEO Hans Maria Heyn as part of the EIT Health Wild Card programme, develops a device for the healthcare industry that provides a real-time monitoring solution for medical diagnostics.

Currently, this process is being managed manually, which can lead to errors and can cause many issues, including slow diagnosis, repeated tests on the patient, and wasted resources. Smart4Diagnostics built Sample-CheckIn to solve this problem, a device it calls a digital human blood sample fingerprint, a data picture of all quality aspects for human blood samples from the collection until lab arrival.